Amex to Trade Options on iShares Nasdaq Biotechnology Index Fund
NEW YORK, Feb. 12, 2002 /PRNewswire/ -- The American Stock Exchange® (Amex®) will launch trading in options on Wednesday, February 13, 2002 on the underlying shares of iShares(SM) Nasdaq Biotechnology Index Fund (IBB).
iShares Nasdaq Biotechnology Index Fund options will open with strike prices of 70 -- 75 -- 80 and position of 13,500 contracts. The options will trade on the March expiration cycle, with initial expirations March, April, June and September. The specialist will be Susquehanna Investment Group.
The iShares(SM) Nasdaq Biotechnology Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Nasdaq Biotechnology Index.
The American Stock Exchange® (Amex®), a subsidiary of the National Association of Securities Dealers, Inc. (NASD®), is the only primary exchange that offers trading across a full range of equities, exchange traded funds (ETFs), including structured products and HOLDRS(SM) and options. In addition to its role as a national equities market, the Amex is the leader in ETF listings, listing 117 ETFs to date, and is the second largest options exchange in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks. For more information, visit amex.com.
SOURCE: The American Stock Exchange |
